home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

199 rows where docket_id = "FDA-2007-D-0369" and posted_year = 2023 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, comment_end_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

document_type 3

  • Other 156
  • Supporting & Related Material 36
  • Notice 7

posted_year 1

  • 2023 · 199 ✖

agency_id 1

  • FDA 199
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2007-D-0369-0949 FDA None FDA-2007-D-0369 PSG_214962 - Draft Guidance on Fingolimod Lauryl Sulfate Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:46Z   1 0 0900006486286f24
FDA-2007-D-0369-0953 FDA None FDA-2007-D-0369 PSG_214120 - Draft Guidance on Azacitidine Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:47Z   1 0 0900006486286f2d
FDA-2007-D-0369-0955 FDA None FDA-2007-D-0369 PSG_214958 - Draft Guidance on Deucravacitinib Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:47Z   1 0 0900006486286f31
FDA-2007-D-0369-0967 FDA None FDA-2007-D-0369 PSG_215446 - Draft Guidance on Edaravone Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:49Z   1 0 0900006486286f4a
FDA-2007-D-0369-0933 FDA None FDA-2007-D-0369 PSG_021254 - Draft Guidance on Fluticasone Propionate; Salmeterol Xinafoate Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:44Z   1 0 0900006486286f00
FDA-2007-D-0369-0938 FDA None FDA-2007-D-0369 PSG_021433 - Draft Guidance on Fluticasone Propionate Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:44Z   1 0 0900006486286f0a
FDA-2007-D-0369-0937 FDA None FDA-2007-D-0369 PSG_014602 - Draft Guidance on Betamethasone Acetate; Betamethasone Sodium Phosphate Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:44Z   1 0 0900006486286f08
FDA-2007-D-0369-0945 FDA None FDA-2007-D-0369 PSG_205641 - Draft Guidance on Mometasone Furoate Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:46Z   1 0 0900006486286f18
FDA-2007-D-0369-0930 FDA None FDA-2007-D-0369 PSG_017643 - Draft Guidance on Soybean Oil Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:43Z   1 0 0900006486287259
FDA-2007-D-0369-0942 FDA None FDA-2007-D-0369 PSG_206317 - Draft Guidance on Ferric Pyrophosphate Citrate Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:45Z   1 0 0900006486286f12
FDA-2007-D-0369-0960 FDA None FDA-2007-D-0369 PSG_215256 - Draft Guidance on Semaglutide Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:48Z   1 0 0900006486286f3c
FDA-2007-D-0369-0948 FDA None FDA-2007-D-0369 PSG_209637 - Draft Guidance on Semaglutide Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-12-14T02:00:54Z   1 0 0900006486286f22
FDA-2007-D-0369-0959 FDA None FDA-2007-D-0369 PSG_215092 - Draft Guidance on Omidenepag Isopropyl Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:48Z   1 0 0900006486286f3a
FDA-2007-D-0369-0962 FDA None FDA-2007-D-0369 PSG_216903 - Draft Guidance on Glycopyrrolate; Neostigmine Methylsulfate Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:49Z   1 0 0900006486286f40
FDA-2007-D-0369-0928 FDA None FDA-2007-D-0369 PSG_021395 - Draft Guidance on Tiotropium Bromide Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:43Z   1 0 0900006486287255
FDA-2007-D-0369-0929 FDA None FDA-2007-D-0369 PSG_020503 - Draft Guidance on Albuterol Sulfate Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:43Z   1 0 0900006486287257
FDA-2007-D-0369-0944 FDA None FDA-2007-D-0369 PSG_022544 - Draft Guidance on Gabapentin Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:45Z   1 0 0900006486286f16
FDA-2007-D-0369-0954 FDA None FDA-2007-D-0369 PSG_209988 - Draft Guidance on Furosemide Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:47Z   1 0 0900006486286f2f
FDA-2007-D-0369-0935 FDA None FDA-2007-D-0369 PSG_017768 - Draft Guidance on Chlorhexidine Gluconate Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:44Z   1 0 0900006486286f04
FDA-2007-D-0369-0964 FDA None FDA-2007-D-0369 PSG_215401 - Draft Guidance on Dextroamphetamine Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:49Z   1 0 0900006486286f44
FDA-2007-D-0369-0966 FDA None FDA-2007-D-0369 PSG_216354 - Draft Guidance on Deutetrabenazine Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:49Z   1 0 0900006486286f48
FDA-2007-D-0369-0958 FDA None FDA-2007-D-0369 PSG_215272 - Draft Guidance on Tapinarof Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:48Z   1 0 0900006486286f38
FDA-2007-D-0369-0927 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-05-16T20:18:05Z 2023-25485 0 0 090000648628cbd3
FDA-2007-D-0369-0934 FDA None FDA-2007-D-0369 PSG_021344 - Draft Guidance on Fulvestrant Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2023-11-17T20:16:37Z   0 0 0900006486286f02
FDA-2007-D-0369-0939 FDA None FDA-2007-D-0369 PSG_208551 - Draft Guidance on Ferric Pyrophosphate Citrate Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:45Z   1 0 0900006486286f0c
FDA-2007-D-0369-0947 FDA None FDA-2007-D-0369 PSG_022180 - Draft Guidance on Ferumoxytol Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:46Z   1 0 0900006486286f20
FDA-2007-D-0369-0957 FDA None FDA-2007-D-0369 PSG_214665 - Draft Guidance on Sotorasib Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:48Z   1 0 0900006486286f36
FDA-2007-D-0369-0931 FDA None FDA-2007-D-0369 PSG_009170 - Draft Guidance on Primidone Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:43Z   1 0 0900006486286efc
FDA-2007-D-0369-0946 FDA None FDA-2007-D-0369 PSG_021897 - Draft Guidance on Naltrexone Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:46Z   1 0 0900006486286f1e
FDA-2007-D-0369-0950 FDA None FDA-2007-D-0369 PSG_209354 - Draft Guidance on Halobetasol Propionate; Tazarotene Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:46Z   1 0 0900006486286f26
FDA-2007-D-0369-0956 FDA None FDA-2007-D-0369 PSG_212860 - Draft Guidance on Ferric Pyrophosphate Citrate Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:47Z   1 0 0900006486286f34
FDA-2007-D-0369-0963 FDA None FDA-2007-D-0369 PSG_215904 - Draft Guidance on Ganaxolone Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:49Z   1 0 0900006486286f42
FDA-2007-D-0369-0932 FDA None FDA-2007-D-0369 PSG_020622 - Draft Guidance on Glatiramer Acetate Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:43Z   1 0 0900006486286efe
FDA-2007-D-0369-0941 FDA None FDA-2007-D-0369 PSG_208215 - Draft Guidance on Emtricitabine; Tenofovir Alafenamide Fumarate Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:45Z   1 0 0900006486286f10
FDA-2007-D-0369-0943 FDA None FDA-2007-D-0369 PSG_021730 - Draft Guidance on Levalbuterol Tartrate Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:45Z   1 0 0900006486286f14
FDA-2007-D-0369-0951 FDA None FDA-2007-D-0369 PSG_210655 - Draft Guidance on Risperidone Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:47Z   1 0 0900006486286f29
FDA-2007-D-0369-0936 FDA None FDA-2007-D-0369 PSG_017920 - Draft Guidance on Cimetidine Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:44Z   1 0 0900006486286f06
FDA-2007-D-0369-0940 FDA None FDA-2007-D-0369 PSG_021929 - Draft Guidance on Budesonide; Formoterol Fumarate Dihydrate Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:45Z   1 0 0900006486286f0e
FDA-2007-D-0369-0952 FDA None FDA-2007-D-0369 PSG_214801 - Draft Guidance on Futibatinib Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:47Z   1 0 0900006486286f2b
FDA-2007-D-0369-0961 FDA None FDA-2007-D-0369 PSG_216472 - Draft Guidance on Latanoprost Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:48Z   1 0 0900006486286f3e
FDA-2007-D-0369-0965 FDA None FDA-2007-D-0369 PSG_215428 - Draft Guidance on Citalopram Hydrobromide Other Guidance 2023-11-17T05:00:00Z 2023 11 2023-11-17T05:00:00Z 2024-01-17T04:59:59Z 2024-11-12T06:22:49Z   1 0 0900006486286f46
FDA-2007-D-0369-0887 FDA None FDA-2007-D-0369 PSG_021258 Draft Guidance on Estradiol; Levonorgestrel Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:05Z   1 0 0900006485ed5b4e
FDA-2007-D-0369-0891 FDA None FDA-2007-D-0369 PSG_201739 Draft Guidance on Epinephrine Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-08-23T03:59:59Z 2024-11-11T21:31:06Z   1 0 0900006485ed5b5c
FDA-2007-D-0369-0921 FDA None FDA-2007-D-0369 PSG_216359 Draft Guidance on Midazolam Hydrochloride Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:08Z   1 0 0900006485ed6325
FDA-2007-D-0369-0902 FDA None FDA-2007-D-0369 PSG_020746 Draft Guidance on Budesonide Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:05Z   1 0 0900006485ed5b46
FDA-2007-D-0369-0888 FDA None FDA-2007-D-0369 PSG_021527 Draft Guidance on Ipratropium Bromide Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:06Z   1 0 0900006485ed5b50
FDA-2007-D-0369-0916 FDA None FDA-2007-D-0369 PSG_216227 Draft Guidance on Chloroprocaine Hydrochloride Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z   2024-11-11T21:31:07Z   1 0 0900006485ed6319
FDA-2007-D-0369-0900 FDA None FDA-2007-D-0369 PSG_008816 Draft Guidance on Lidocaine Hydrochloride Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:04Z   1 0 0900006485ed5b42
FDA-2007-D-0369-0915 FDA None FDA-2007-D-0369 PSG_215833 Draft Guidance on Lutetium Lu-177 Vipivotide Tetraxetan Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:07Z   1 0 0900006485ed627c
FDA-2007-D-0369-0901 FDA None FDA-2007-D-0369 PSG_020468 Draft Guidance on Triamcinolone Acetonide Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:05Z   1 0 0900006485ed5b44
FDA-2007-D-0369-0896 FDA None FDA-2007-D-0369 PSG_213433 Draft Guidance on Clascoterone Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-07T01:23:13Z   1 0 0900006485ed5c47
FDA-2007-D-0369-0905 FDA None FDA-2007-D-0369 PSG_214487 Draft Guidance on Avacopan Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-07T01:23:37Z   1 0 0900006485ed5c59
FDA-2007-D-0369-0914 FDA None FDA-2007-D-0369 PSG_214662 Draft Guidance on Maralixibat Chloride Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-07T01:23:40Z   1 0 0900006485ed5c77
FDA-2007-D-0369-0920 FDA None FDA-2007-D-0369 PSG_215866 Draft Guidance on Tirzepatide Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2025-02-23T05:15:13Z   1 0 0900006485ed6321
FDA-2007-D-0369-0907 FDA None FDA-2007-D-0369 PSG_214103 Draft Guidance on Lumasiran Sodium Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-07T01:23:38Z   1 0 0900006485ed5c5d
FDA-2007-D-0369-0911 FDA None FDA-2007-D-0369 PSG_214998 Draft Guidance on Mavacamten Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-07T01:23:38Z   1 0 0900006485ed5c71
FDA-2007-D-0369-0904 FDA None FDA-2007-D-0369 PSG_214028 Draft Guidance on Pilocarpine Hydrochloride Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-07T01:23:37Z   1 0 0900006485ed5c4d
FDA-2007-D-0369-0890 FDA None FDA-2007-D-0369 PSG_022004 Draft Guidance on Ciclesonide Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:06Z   1 0 0900006485ed5b5a
FDA-2007-D-0369-0892 FDA None FDA-2007-D-0369 PSG_205920 Draft Guidance on Epinephrine Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:06Z   1 0 0900006485ed5b5e
FDA-2007-D-0369-0917 FDA None FDA-2007-D-0369 PSG_215888 Draft Guidance on Oteseconazole Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:07Z   1 0 0900006485ed631b
FDA-2007-D-0369-0919 FDA None FDA-2007-D-0369 PSG_216196 Draft Guidance on Mitapivat Sulfate Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z   2024-11-11T21:31:08Z   1 0 0900006485ed631f
FDA-2007-D-0369-0885 FDA None FDA-2007-D-0369 PSG_020911 Draft Guidance on Beclomethasone Dipropionate Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:05Z   1 0 0900006485ed5b4a
FDA-2007-D-0369-0903 FDA None FDA-2007-D-0369 PSG_021234 Draft Guidance on Diclofenac Epolamine Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:05Z   1 0 0900006485ed5b48
FDA-2007-D-0369-0893 FDA None FDA-2007-D-0369 PSG_208712 Draft Guidance on Pacritinib Citrate Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-07T01:23:12Z   1 0 0900006485ed5c34
FDA-2007-D-0369-0897 FDA None FDA-2007-D-0369 PSG_213137 Draft Guidance on Voxelotor Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-07T01:23:13Z   1 0 0900006485ed5c49
FDA-2007-D-0369-0906 FDA None FDA-2007-D-0369 PSG_213581 Draft Guidance on Atropine Sulfate Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-08-23T03:59:59Z 2024-11-07T01:23:37Z   1 0 0900006485ed5c5b
FDA-2007-D-0369-0884 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z   2023-08-22T13:37:43Z 2023-18026 0 0 0900006485ed5264
FDA-2007-D-0369-0886 FDA None FDA-2007-D-0369 PSG_021658 Draft Guidance on Ciclesonide Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:05Z   1 0 0900006485ed5b4c
FDA-2007-D-0369-0918 FDA None FDA-2007-D-0369 PSG_215358 Draft Guidance on Asciminib Hydrochloride Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:08Z   1 0 0900006485ed631d
FDA-2007-D-0369-0898 FDA None FDA-2007-D-0369 PSG_212097 Draft Guidance on Glucagon Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-07T01:23:40Z   1 0 0900006485ed5c4b
FDA-2007-D-0369-0909 FDA None FDA-2007-D-0369 PSG_214985 Draft Guidance on Daridorexant Hydrochloride Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-07T01:23:38Z   1 0 0900006485ed5c61
FDA-2007-D-0369-0895 FDA None FDA-2007-D-0369 PSG_211746 Draft Guidance on Mometasone Furoate; Olopatadine Hydrochloride Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-07T01:23:13Z   1 0 0900006485ed5c45
FDA-2007-D-0369-0908 FDA None FDA-2007-D-0369 PSG_213871 Draft Guidance on Abrocitinib Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-07T01:23:38Z   1 0 0900006485ed5c5f
FDA-2007-D-0369-0912 FDA None FDA-2007-D-0369 PSG_215310 Draft Guidance on Mobocertinib Succinate Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-08-23T03:59:59Z 2024-11-07T01:23:38Z   1 0 0900006485ed5c73
FDA-2007-D-0369-0899 FDA None FDA-2007-D-0369 PSG_019389 Draft Guidance on Beclomethasone Dipropionate Monohydrate Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:04Z   1 0 0900006485ed5b27
FDA-2007-D-0369-0889 FDA None FDA-2007-D-0369 PSG_022033 Draft Guidance on Fluvoxamine Maleate Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:06Z   1 0 0900006485ed5b58
FDA-2007-D-0369-0922 FDA None FDA-2007-D-0369 PSG_215515 Draft Guidance on Vutrisiran Sodium Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-11T21:31:08Z   1 0 0900006485ed6327
FDA-2007-D-0369-0910 FDA None FDA-2007-D-0369 PSG_215206 Draft Guidance on Atogepant Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-07T01:23:38Z   1 0 0900006485ed5c6f
FDA-2007-D-0369-0894 FDA None FDA-2007-D-0369 PSG_207921 Draft Guidance on Beclomethasone Dipropionate Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-07T01:23:12Z   1 0 0900006485ed5c36
FDA-2007-D-0369-0913 FDA None FDA-2007-D-0369 PSG_215309 Draft Guidance on Ruxolitinib Phosphate Other Guidance 2023-08-22T04:00:00Z 2023 8 2023-08-22T04:00:00Z 2023-10-24T03:59:59Z 2024-11-07T01:23:40Z   1 0 0900006485ed5c75
FDA-2007-D-0369-0867 FDA None FDA-2007-D-0369 PSG_214793 - Draft Guidance on Piflufolastat F-18 Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:12Z   1 0 0900006485a20d0a
FDA-2007-D-0369-0868 FDA None FDA-2007-D-0369 PSG_214916 - Draft Guidance on Difelikefalin Acetate Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-18T03:59:59Z 2024-11-07T01:34:15Z   1 0 0900006485a20c85
FDA-2007-D-0369-0860 FDA None FDA-2007-D-0369 PSG_213691- Draft Guidance on Clobetasol Propionate Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:19Z   1 0 0900006485a204e2
FDA-2007-D-0369-0866 FDA None FDA-2007-D-0369 PSG_214783 - Draft Guidance on Belumosudil Mesylate Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:14Z   1 0 0900006485a20c81
FDA-2007-D-0369-0871 FDA None FDA-2007-D-0369 PSG_215457 - Draft Guidance on Naloxone Hydrochloride Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:13Z   1 0 0900006485a20c89
FDA-2007-D-0369-0874 FDA None FDA-2007-D-0369 PSG_018152 - Draft Guidance on Lithium Carbonate Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:18Z   1 0 0900006485a23167
FDA-2007-D-0369-0857 FDA None FDA-2007-D-0369 Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability Notice Notice of Availability 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z   2023-05-19T15:39:54Z 2023-10710 0 0 0900006485a22a81
FDA-2007-D-0369-0865 FDA None FDA-2007-D-0369 PSG_214461 - Draft Guidance on Brincidofovir Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:14Z   1 0 0900006485a2057a
FDA-2007-D-0369-0863 FDA None FDA-2007-D-0369 PSG_214410 - Draft Guidance on Baloxavir Marboxil Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:11Z   1 0 0900006485a20577
FDA-2007-D-0369-0875 FDA None FDA-2007-D-0369 PSG_018558 - Draft Guidance on Lithium Carbonate Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:18Z   1 0 0900006485a23169
FDA-2007-D-0369-0858 FDA None FDA-2007-D-0369 PSG_213312 Draft Guidance on Sirolimus Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:10Z   1 0 0900006485a1e362
FDA-2007-D-0369-0861 FDA None FDA-2007-D-0369 PSG_213026 - Draft Guidance on Casimersen Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:14Z   1 0 0900006485a20573
FDA-2007-D-0369-0862 FDA None FDA-2007-D-0369 PSG_214012- Draft Guidance on Inclisiran Sodium Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:14Z   1 0 0900006485a20575
FDA-2007-D-0369-0876 FDA None FDA-2007-D-0369 PSG_207925 - Draft Guidance on Ivacaftor Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:14Z   1 0 0900006485a2283a
FDA-2007-D-0369-0872 FDA None FDA-2007-D-0369 PSG_211911- Draft Guidance on Bimatoprost Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:22Z   1 0 0900006485a22d9c
FDA-2007-D-0369-0869 FDA None FDA-2007-D-0369 PSG_215341- Draft Guidance on Finerenone Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:16Z   1 0 0900006485a20d0d
FDA-2007-D-0369-0864 FDA None FDA-2007-D-0369 PSG_214460 - Draft Guidance on Brincidofovir Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:12Z   1 0 0900006485a204e5
FDA-2007-D-0369-0870 FDA None FDA-2007-D-0369 PSG_215383 - Draft Guidance on Belzutifan) Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:16Z   1 0 0900006485a20d0f
FDA-2007-D-0369-0873 FDA None FDA-2007-D-0369 PSG_212194 -Draft Guidance on Givosiran Sodium Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:09Z   1 0 0900006485a22802
FDA-2007-D-0369-0859 FDA None FDA-2007-D-0369 PSG_213426 - Draft Guidance on Celecoxib; Tramadol Hydrochloride Other Guidance 2023-05-19T04:00:00Z 2023 5 2023-05-19T04:00:00Z 2023-07-19T03:59:59Z 2024-11-07T01:34:07Z   1 0 0900006485a20571

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 2987.177ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API